Search Results - "Weder, W"

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Crinò, L., Weder, W., van Meerbeeck, J., Felip, E.

Get full text

Pleural mesothelioma: is the surgeon still there? by Opitz, I., Weder, W.

“…Malignant pleural mesothelioma (MPM) is a rare malignancy with some unique characteristics. Tumor biology is aggressive and prognosis is poor. Despite more…”
Get full text

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma by Scherpereel, A, Astoul, P, Baas, P, Berghmans, T, Clayson, H, de Vuyst, P, Dienemann, H, Galateau-Salle, F, Hennequin, C, Hillerdal, G, Le Pechoux, C, Mutti, L, Pairon, J-C, Stahel, R, van Houtte, P, van Meerbeeck, J, Waller, D, Weder, W

“…Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a poor prognosis. In 2008, the European Respiratory Society/European…”
Get full text

Advances in surgery by Weder, W

“…In the last decade, technological advances, new staging tools, better understanding the role of surgery within multimodal treatment concepts in advanced stages…”
Get full text

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer by Eberhardt, W.E.E., De Ruysscher, D., Weder, W., Le Péchoux, C., De Leyn, P., Hoffmann, H., Westeel, V., Stahel, R., Felip, E., Peters, S., Stahel, Rolf, Felip, Enriqueta, Peters, Solange, Kerr, Keith, Besse, Benjamin, Vansteenkiste, Johan, Eberhardt, Wilfried, Edelman, Martin, Mok, Tony, O'Byrne, Ken, Novello, Silvia, Bubendorf, Lukas, Marchetti, Antonio, Baas, Paul, Reck, Martin, Syrigos, Konstantinos, Paz-Ares, Luis, Smit, Egbert F., Meldgaard, Peter, Adjei, Alex, Nicolson, Marianne, Crinó, Lucio, Van Schil, Paul, Senan, Suresh, Faivre-Finn, Corinne, Rocco, Gaetano, Veronesi, Giulia, Douillard, Jean-Yves, Lim, Eric, Dooms, Christophe, Weder, Walter, De Ruysscher, Dirk, Le Pechoux, Cecile, De Leyn, Paul, Westeel, Virginie

“…To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour…”
Get full text

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial by Hiltbrunner, S., Britschgi, C., Schuberth, P., Bankel, L., Nguyen-Kim, T.D.L., Gulati, P., Weder, W., Opitz, I., Lauk, O., Caviezel, C., Bachmann, H., Tabor, A., Schröder, P., Knuth, A., Münz, C., Stahel, R., Boyman, O., Renner, C., Petrausch, U., Curioni-Fontecedro, A.

Get full text

Mesothelioma by Weder, W

Get full text

Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? by FRAUENFELDER, T, TUTIC, M, WEDER, W, GÖTTI, R. P, STAHEL, R. A, SEIFERT, B, OPITZ, I

“…The purpose of our study was to assess robustness of volumetric measurement of malignant pleural mesothelioma (MPM) before and after chemotherapy to modified…”
Get full text

Searching for targets for the systemic therapy of mesothelioma by Stahel, R.A., Weder, W., Felley-Bosco, E., Petrausch, U., Curioni-Fontecedro, A., Schmitt-Opitz, I., Peters, S.

“…Malignant mesothelioma is an incurable disease associated with asbestos exposure arising in the pleural cavity and less frequently in the peritoneal cavity…”
Get full text

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma by Weder, W, Stahel, RA, Bernhard, J, Bodis, S, Vogt, P, Ballabeni, P, Lardinois, D, Betticher, D, Schmid, R, Stupp, R, Ris, HB, Jermann, M, Mingrone, W, Roth, AD, Spiliopoulos, A

“…Background: The aim of this multicenter trial was to prospectively evaluate neo-adjuvant chemotherapy followed by extrapleural pneumonectomy (EPP) and…”
Get full text

The Technique of Orthotopic Mouse Lung Transplantation as a Movie—Improved Learning by Visualization by Jungraithmayr, W., Weder, W.

“…The introduction of the mouse model of orthotopic single‐lung transplantation has significantly advanced research in experimental lung transplantation…”
Get full text

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients by Pavic, M., Bogowicz, M., Kraft, J., Vuong, D., Mayinger, M., Kroeze, S. G. C., Friess, M., Frauenfelder, T., Andratschke, N., Huellner, M., Weder, W., Guckenberger, M., Tanadini-Lang, S., Opitz, I.

“…Background Careful selection of malignant pleural mesothelioma (MPM) patients for curative treatment is of highest importance, as the multimodal treatment…”
Get full text

Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors by Echeverry, N, Ziltener, G, Barbone, D, Weder, W, Stahel, R A, Broaddus, V C, Felley-Bosco, E

“…Malignant pleural mesothelioma (MPM) originates in most of the cases from chronic inflammation of the mesothelium due to exposure to asbestos fibers. Given the…”
Get full text

Lung cancer: new opportunities—changing algorithm in staging by Weder, W.

Get full text

Lung surgery in the elderly today by Rocco, G, Weder, W

“…Abstract The ever increasing life expectancy in the general population has prompted the multiplication of institutional reports focusing on the surgical…”
Get full text

CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation by Jungraithmayr, Wolfgang, De Meester, Ingrid, Matheeussen, Veerle, Baerts, Lesley, Arni, Stephan, Weder, Walter

“…OBJECTIVES The CD26 antigen is a transmembrane glycoprotein that is constitutively expressed on activated lymphocytes and in pulmonary parenchyma. This…”
Get full text

Smoking prevention intervention with school classes in university hospital by thoracic surgeon und pulmonologist. The Zurich prevention project by Furrer, K., Schuurmans, M.M., Hebeisen, M., Schulte, S., Schneiter, D., Weder, W., Opitz, I., Hillinger, S.

“…•Smoking prevention for scholars by lung specialists in hospital is feasible.•The intervention program for pupils on health effects of smoking is well…”
Get full text

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug by Stahel, R.A., Curioni-Fontecedro, A., Rohrmann, S., Dafni, U., Sandner, U., Opitz, I., Andratschke, N., Franzen, D., Dimopoulou, G., Matthes, K.L., Kohler, M., Guckenberger, M., Weder, W.

“…•Survival outcome of patients with NSCLC treated by a dedicated multidisciplinary team within the structure of a Comprehensive Cancer Center…”
Get full text

Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: A prospective randomized blinded study by Moser, C., MD, Opitz, I., MD, Zhai, W., MD, Rousson, V., MD, Russi, E.W., MD, Weder, W., MD, Lardinois, D., MD

“…Objective Prolonged air leak is reported in up to 50% of patients after lung volume reduction surgery. The effect of an autologous fibrin sealant on the…”
Get full text

38IN NSCLC STAGE I AND II by Weder, W

Get full text